Literature DB >> 10835516

ras gene mutations in salivary gland tumors.

J Yoo1, R A Robinson.   

Abstract

OBJECTIVE: To assess the prevalence of activating mutations in K-ras and H-ras genes in salivary gland tumors with ductal or acinar differentiation and to evaluate their potential correlation with clinical parameters.
DESIGN: Paraffin-embedded tissue samples of salivary gland carcinomas were investigated by the application of a direct sequence analysis procedure with automated DNA sequencing of polymerase chain reaction-amplified ras sequences.
SETTING: Tertiary care teaching hospital. PATIENTS: Twenty-four patients with salivary gland carcinoma were surgically treated. Nine had adenocarcinoma, 1 had adenosquamous carcinoma, 11 had mucoepidermoid carcinoma, and 3 had acinic cell carcinoma.
RESULTS: Point mutations were detected in 7 (29%) of the 24 carcinomas examined. The K-ras gene was mutated in only 2 samples (8%): a GGC-to-ATC mutation at codon 13 in an adenocarcinoma and a GGC-to-GTC transversion mutation at codon 13 in a mucoepidermoid carcinoma. Five (21%) harbored H-ras mutations: 4 contained a GGC-to-GTC transversion mutation at codon 12 and 1 had 2 distinct mutations, the same G-to-T at codon 12 as was shown in the other cases and a GGT-to-GGA heterozygous mutation at codon 13. All the H-ras mutations were in the group of mucoepidermoid carcinoma lesions (45%; 5/11).
CONCLUSION: Our data suggest that K-ras gene alteration is probably not an important factor in the oncogenesis of human salivary gland tumors. However, mutational activation of the H-ras gene appears to play a role in the development and/or progression of salivary gland mucoepidermoid carcinomas.

Entities:  

Mesh:

Year:  2000        PMID: 10835516     DOI: 10.5858/2000-124-0836-RGMISG

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  8 in total

1.  Functional specificity of ras isoforms: so similar but so different.

Authors:  Esther Castellano; Eugenio Santos
Journal:  Genes Cancer       Date:  2011-03

2.  Overexpression of sphingosine kinase 1 is associated with salivary gland carcinoma progression and might be a novel predictive marker for adjuvant therapy.

Authors:  Guanglin Liu; Haiqing Zheng; Zhibing Zhang; Zhiqiang Wu; Huaping Xiong; Jun Li; Libing Song
Journal:  BMC Cancer       Date:  2010-09-16       Impact factor: 4.430

3.  Phosphorylated epidermal growth factor receptor expression and KRAS mutation status in salivary gland carcinomas.

Authors:  T Schneider; A Strehl; C Linz; R Brands; S Hartmann; F Beckford; A Rosenwald; A C Kübler; U D A Müller-Richter
Journal:  Clin Oral Investig       Date:  2015-08-06       Impact factor: 3.573

4.  Activated Kras, but not Hras or Nras, may initiate tumors of endodermal origin via stem cell expansion.

Authors:  Margaret P Quinlan; Steven E Quatela; Mark R Philips; Jeffrey Settleman
Journal:  Mol Cell Biol       Date:  2008-02-11       Impact factor: 4.272

5.  HRAS mutations in epithelial-myoepithelial carcinoma.

Authors:  Simion I Chiosea; Megan Miller; Raja R Seethala
Journal:  Head Neck Pathol       Date:  2013-11-26

6.  Activation of the EGFR/ERK pathway in high-grade mucoepidermoid carcinomas of the salivary glands.

Authors:  B Lujan; S Hakim; S Moyano; A Nadal; M Caballero; A Diaz; A Valera; M Carrera; A Cardesa; L Alos
Journal:  Br J Cancer       Date:  2010-07-27       Impact factor: 7.640

7.  Differential in vivo tumorigenicity of diverse KRAS mutations in vertebrate pancreas: A comprehensive survey.

Authors:  J T Park; N Johnson; S Liu; M Levesque; Y J Wang; H Ho; D Huso; A Maitra; M J Parsons; J D Prescott; S D Leach
Journal:  Oncogene       Date:  2014-07-28       Impact factor: 9.867

Review 8.  Particular aspects in the cytogenetics and molecular biology of salivary gland tumours - current review of reports.

Authors:  Aleksandra J Ochal-Choińska; Ewa Osuch-Wójcikiewicz
Journal:  Contemp Oncol (Pozn)       Date:  2016-09-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.